Finance

Beta
Lists
524322:BOM
Kabra Drugs Ord Shs
₹23.19
+8.21%
(+1.76) 1D
Jun 12, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524322...
Open
₹22.20
High
₹25.02
Low
₹21.75
Avg. vol.
89.31K
Volume
63.46K
52-wk high
₹35.52
52-wk low
₹12.21
No. of employees
31
Open
₹22.20
High
₹25.02
Low
₹21.75
Avg. vol.
89.31K
Volume
63.46K
52-wk high
₹35.52
52-wk low
₹12.21
No. of employees
31
News stories
From sources across the web
About Kabra Drugs Ord Shs
CEO-
Employees31
Founded1989
Headquarters-
SectorPharmaceutical industry
Websitekabradrugs.com
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
71.50M
197.64M
304.20M
354.06M
Cost of goods sold
67.50M
165.24M
273.24M
330.66M
Cost of revenue
67.50M
165.24M
273.24M
330.66M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.78M
3.57M
3.85M
3.46M
Operating expense
9.16M
12.14M
6.77M
10.18M
Total operating expenses
76.66M
177.38M
280.01M
340.84M
Operating income
-5.16M
20.26M
24.19M
13.22M
Other non operating income
163.00K
1.79M
1.84M
1.13M
EBT including unusual items
-5.00M
22.05M
26.01M
14.20M
EBT excluding unusual items
-5.00M
22.05M
26.01M
14.20M
Income tax expense
-
3.68M
341.00K
3.57M
Effective tax rate
-
16.70%
1.31%
25.12%
Other operating expenses
5.35M
8.45M
2.79M
6.55M
Net income
-5.00M
18.37M
25.66M
10.63M
Net profit margin
-6.99%
9.29%
8.44%
3.00%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-25.00K
-147.00K
Net interest expenses
-
-
-25.00K
-147.00K
Depreciation and amortization charges
34.00K
120.00K
127.00K
175.00K
EBITDA
-5.14M
20.34M
24.21M
13.31M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer